Unknown

Dataset Information

0

Anacetrapib-driven triglyceride lowering explained: the fortuitous role of CETP in the intravascular catabolism of triglyceride-rich lipoproteins.

ABSTRACT:

SUBMITTER: Brown AL 

PROVIDER: S-EPMC5454498 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Anacetrapib-driven triglyceride lowering explained: the fortuitous role of CETP in the intravascular catabolism of triglyceride-rich lipoproteins.

Brown Amanda L AL   Brown J Mark JM  

Journal of lipid research 20170421 6

Similar Datasets

Unknown New Therapies for Lowering Triglyceride-Rich Lipoproteins: JACC Focus Seminar 3/4.
| S-EPMC9327673 | biostudies-literature
Unknown Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis.
| S-EPMC9174947 | biostudies-literature
Unknown Endothelial lipase mediates efficient lipolysis of triglyceride-rich lipoproteins.
| S-EPMC8483387 | biostudies-literature
Unknown Managing of Dyslipidaemia Characterized by Accumulation of Triglyceride-Rich Lipoproteins.
| S-EPMC8924084 | biostudies-literature
Unknown Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease.
| S-EPMC4866746 | biostudies-literature
Unknown Case report: a potential modulation of coronary atheroma by lowering triglyceride-rich lipoproteins with pemafibrate: insights from serial near-infrared spectroscopy imaging.
| S-EPMC9971301 | biostudies-literature
Unknown Effects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolism.
| S-EPMC3351826 | biostudies-literature
Unknown PNPLA2 influences secretion of triglyceride-rich lipoproteins by human hepatoma cells.
| S-EPMC6547638 | biostudies-literature
Unknown Measurement of LDL-C after treatment with the CETP inhibitor anacetrapib.
| S-EPMC3588873 | biostudies-literature
Unknown Metabolism of apolipoprotein A-II containing triglyceride rich ApoB lipoproteins in humans.
| S-EPMC4509984 | biostudies-literature